Literature DB >> 23172653

Enhanced cortisol suppression following administration of low-dose dexamethasone in first-episode psychosis patients.

Christina Phassouliotis1, Belinda A Garner, Lisa J Phillips, Sarah Bendall, Yang Yun, Connie Markulev, Melissa Kerr, Patrick D McGorry.   

Abstract

OBJECTIVE: Impaired regulation of the hypothalamic-pituitary-adrenal (HPA) axis and hyper-activity of this system have been described in patients with psychosis. Conversely, some psychiatric disorders such as post-traumatic stress disorder (PTSD) are characterised by HPA hypo-activity, which could be related to prior exposure to trauma. This study examined the cortisol response to the administration of low-dose dexamethasone in first-episode psychosis (FEP) patients and its relationship to childhood trauma.
METHOD: The low-dose (0.25 mg) Dexamethasone Suppression Test (DST) was performed in 21 neuroleptic-naïve or minimally treated FEP patients and 20 healthy control participants. Childhood traumatic events were assessed in all participants using the Childhood Trauma Questionnaire (CTQ) and psychiatric symptoms were assessed in patients using standard rating scales.
RESULTS: FEP patients reported significantly higher rates of childhood trauma compared to controls (p = 0.001) and exhibited lower basal (a.m.) cortisol (p = 0.04) and an increased rate of cortisol hyper-suppression following dexamethasone administration compared to controls (33% (7/21) vs 5% (1/20), respectively; p = 0.04). There were no significant group differences in mean cortisol decline or percent cortisol suppression following the 0.25 mg DST. This study shows for the first time that a subset of patients experiencing their first episode of psychosis display enhanced cortisol suppression.
CONCLUSIONS: These findings suggest there may be distinct profiles of HPA axis dysfunction in psychosis which should be further explored.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23172653     DOI: 10.1177/0004867412465125

Source DB:  PubMed          Journal:  Aust N Z J Psychiatry        ISSN: 0004-8674            Impact factor:   5.744


  7 in total

Review 1.  The role of cortisol in first episode of psychosis: a systematic review.

Authors:  Evangelos Karanikas; Diomidis Antoniadis; George D Garyfallos
Journal:  Curr Psychiatry Rep       Date:  2014-11       Impact factor: 5.285

2.  Mild early-life stress exaggerates the impact of acute stress on corticolimbic resting-state functional connectivity.

Authors:  Huan Wang; Judith M C van Leeuwen; Lycia D de Voogd; Robbert-Jan Verkes; Benno Roozendaal; Guillén Fernández; Erno J Hermans
Journal:  Eur J Neurosci       Date:  2021-12-01       Impact factor: 3.698

3.  Reproducibility and utility of an overnight 0.25 mg dexamethasone suppression test as a marker for glucocorticoid sensitivity in children with asthma.

Authors:  R H Willemsen; L van Leeuwen; T A S Voorend-van Bergen; Y B de Rijke; M W Pijnenburg; E L T van den Akker
Journal:  J Endocrinol Invest       Date:  2015-06-10       Impact factor: 4.256

Review 4.  The Role of Trauma and Stressful Life Events among Individuals at Clinical High Risk for Psychosis: A Review.

Authors:  Danessa Mayo; Sarah Corey; Leah H Kelly; Seghel Yohannes; Alyssa L Youngquist; Barbara K Stuart; Tara A Niendam; Rachel L Loewy
Journal:  Front Psychiatry       Date:  2017-04-20       Impact factor: 4.157

Review 5.  Inflammation, Stress Response, and Redox Dysregulation Biomarkers: Clinical Outcomes and Pharmacological Implications for Psychosis.

Authors:  Stefania Schiavone; Luigia Trabace
Journal:  Front Psychiatry       Date:  2017-10-25       Impact factor: 4.157

6.  Dynamic Patterns of Threat-Associated Gene Expression in the Amygdala and Blood.

Authors:  Adriana Lori; Stephanie A Maddox; Sumeet Sharma; Raül Andero; Kerry J Ressler; Alicia K Smith
Journal:  Front Psychiatry       Date:  2019-01-17       Impact factor: 4.157

Review 7.  Early Life Stress and Pediatric Posttraumatic Stress Disorder.

Authors:  Panagiota Pervanidou; Gerasimos Makris; George Chrousos; Agorastos Agorastos
Journal:  Brain Sci       Date:  2020-03-14
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.